EtEraser™ SE Endotoxin Removal Kit
1. Product information
We are the expert of endotoxin testing and endotoxin
removal. We offer the complete solutions covering the whole range of endotoxin
control, endotoxin monitoring and testing. Our products include laboratory
research uses endotoxin removal kits and could be scaled up to industrial
production scale columns. Lipopolysaccharide (LPS) is a bacterial endotoxin and
a major constituent of the cell walls of gram-negative bacteria. Recombinant
protein from E.coli usually contains high level of endotoxins. The
removal of these endotoxins is highly necessary for downstream processes.
EtEraser HP Endotoxin Removal Kit are designed to remove endotoxin
contamination from aqueous solutions. The kits contain endotoxin removal resin
binds to reduce endotoxin levels in protein samples by ≥99% in less than 2
hours.
2.
Product features
◆ high stability --- does not affect
the activity of most of the biological sample
◆ high protein recovery --- >95%
protein recovery for protein samples
◆ high removal efficiency --- remove
>99% endotoxin,endotoxin level in the sample can be less than 0.1 EU/ml
after endotoxin removing process
◆ wide application range --- can be
used in endotoxin removal for proteins, peptides, antibodies, vaccines,
polysaccharide and other biological samples
EtEraser
HP High Efficient endotoxin removal kit utilizes immobilized affinity ligand
modified PMB to bind and remove endotoxin from aqueous solution. The modified
PMB (polymyxin B) ligand is a high specific endotoxin binding ligand. The
column has very high protein recovery rate for more than 95%. Endotoxin level
in the sample can be less than 0.1 EU/ml after endotoxin removing process.
The kit
includes a pre-packed endotoxin removal column 1.5 ml, Equilibration Buffer,
Regeneration Buffer and pyrogen-free collection tube and tips. The column has a
high binding capacity of > 2, 000, 000 EU / ml. This product may be reused
up to five times if properly regenerated. The affinity resin is available in
slurry and could be up-scaling in biopharmaceutical process.
